15 Results

People

  1. Brentjens
    Brentjens
  2. Park
    Park
  3. Purdon
    Purdon
  4. Halton
    Halton
  5. Riviere
    Riviere
  6. Wang
    Wang
  7. Sadelain
    Sadelain
  8. Bernal
    Bernal
  9. Curran
    Curran
  10. Sauter
    Sauter

Groups

  1. Adult Leukemia (15)
  2. Center for Hematologic Malignancies (15)
  3. Department of Medicine (15)
  4. GSK Faculty (15)
  5. Hematologic Malignancies Research (15)
  6. Hematologic Malignancies, Division of (15)
  7. Nursing (15)
  8. Advanced Practice Providers (14)
  9. Molecular Pharmacology and Chemistry Program Faculty (11)
  10. Sloan Kettering Institute Faculty (11)
  1. "Hematologic Malignancies Research"
  2. "Nursing"
  3. "Terence Purdon"
Formats
  1. Meeting Abstract (10)
  2. Journal Article (5)
Groups
  1. Adult Leukemia (15)
  2. Center for Hematologic Malignancies (15)
  3. Department of Medicine (15)
  4. GSK Faculty (15)
  5. Hematologic Malignancies Research (15)
  6. Hematologic Malignancies, Division of (15)

More Groups

People
  1. Jae Park (15)
  2. Renier Brentjens (15)
  3. Terence Purdon (15)
  4. Elizabeth Halton (14)
  5. Isabelle Riviere (14)
  6. Xiuyan Wang (12)

More People

Years
  1. 2020 (1)
  2. 2019 (2)
  3. 2018 (4)
  4. 2017 (3)
  5. 2015 (3)
  6. 2014 (1)

More Years

Publications
  1. Blood (6)
  2. Journal of Clinical Oncology (3)
  3. Blood Advances (1)
  4. Cancer Discovery (1)
  5. Haematologica (1)
  6. JCI Insight (1)

More Publications

Publishers
  1. American Society of Hematology (7)
  2. American Society of Clinical Oncology (3)
  3. Amer Soc Clinical Investigation Inc (1)
  4. American Association for Cancer Research (1)
  5. Ferrata Storti Foundation (1)
  6. Lippincott Williams & Wilkins (1)

More Publishers

Results (15)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Hematopoietic recovery in patients receiving chimeric antigen receptor T-cell therapy for hematologic malignancies
    Journal Article

    Jain, T.; Knezevic, A.; Pennisi, M.; Chen, Y.; Ruiz, J. D.; Purdon, T. J.; Devlin, S. M.; Smith, M.; Shah, G. L.; Halton, E.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • CD19 CAR T cells following autologous transplantation in poor-risk relapsed and refractory B-cell non-Hodgkin lymphoma
    Journal Article

    Sauter, C. S.; Senechal, B.; Rivière, I.; Ni, A.; Bernal, Y.; Wang, X.; Purdon, T.; Hall, M.; Singh, A. N.; Szenes, V. Z.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Safety and tolerability of conditioning chemotherapy followed by CD19-targeted CAR T cells for relapsed/refractory CLL
    Journal Article

    Geyer, M. B.; Riviere, I.; Senechal, B.; Wang, X.; Wang, Y.; Purdon, T. J.; Hsu, M.; Devlin, S. M.; Palomba, M. L.; Halton, E.; more...
    JCI Insight (2019)

    Fulltext@MSK | Save
  • Clinical responses and pharmacokinetics of MCARH171, a human-derived BCMA targeted CAR T cell therapy in relapsed/refractory multiple myeloma: Final results of a phase I clinical trial
    Meeting Abstract

    Mailankody, S.; Ghosh, A.; Staehr, M.; Purdon, T. J.; Roshal, M.; Halton, E.; Diamonte, C.; Pineda, J.; Anant, P.; Bernal, Y.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Neurotoxicity associated with CD19-specific chimeric antigen receptor T cell therapy for adult acute lymphoblastic leukemia (B-ALL)
    Meeting Abstract

    Santomasso, B.; Park, J. H.; Riviere, I.; Mead, E.; Li, D.; Senechal, B.; Purdon, T.; Halton, E.; Diamonte, C.; Sadelain, M.; more...
    Neurology (2018)

    Fulltext@MSK | Save
  • Clinical and biological correlates of neurotoxicity associated with CAR T-cell therapy in patients with B-cell acute lymphoblastic leukemia
    Journal Article

    Santomasso, B. D.; Park, J. H.; Salloum, D.; Riviere, I.; Flynn, J.; Mead, E.; Halton, E.; Wang, X.; Senechal, B.; Purdon, T.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • Autologous CD19-Targeted CAR T cells in patients with residual CLL following initial purine analog-based therapy
    Journal Article

    Geyer, M. B.; Rivière, I.; Sénéchal, B.; Wang, X.; Wang, Y.; Purdon, T. J.; Hsu, M.; Devlin, S. M.; Halton, E.; Lamanna, N.; more...
    Molecular Therapy (2018)

    Fulltext@MSK | Save
  • Biomarkers associated with neurotoxicity in adult patients with relapsed or refractory B-ALL (R/R B-ALL) treated with CD19 CAR T cells
    Meeting Abstract

    Santomasso, B.; Park, J. H.; Riviere, I.; Mead, E.; Halton, E.; Diamonte, C.; Purdon, T.; Senechal, B.; Li, D.; Sadelain, M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Baseline and early post-treatment clinical and laboratory factors associated with severe neurotoxicity following 19-28z CAR T cells in adult patients with relapsed B-ALL
    Meeting Abstract

    Park, J. H.; Santomasso, B.; Riviere, I.; Senechal, B.; Wang, X.; Purdon, T.; Wang, Y.; Halton, E.; Diamonte, C.; Li, D.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Development and evaluation of a human single chain variable fragment (scFv) derived BCMA targeted CAR T Cell vector leads to a high objective response rate in patients with advanced MM
    Meeting Abstract

    Smith, E. L.; Mailankody, S.; Ghosh, A.; Masakayan, R.; Staehr, M.; Purdon, T. J.; Halton, E.; Diamonte, C.; Anant, P.; Bernal, Y.; more...
    Blood (2017)

    Fulltext@MSK | Save